Management of abemaciclib associated adverse events in patients with hormone receptor positive (HR+), HER2- advanced breast cancer: Analysis of the MONARCH trials

H. S. Rugo, S. M. Tolaney, J. Huober, M. Toi, V. André, S. Barriga, T. Forrester, G. W. Sledge, M. P. Goetz

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)viii110-viii111
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this